52238 Updated integrated safety analysis of ritlecitinib over 36 months in patients with alopecia areata (AA) from the ALLEGRO clinical trial program

Authors
Category Systematic review
JournalJ. Am. Acad. Dermatol.
Year 2024
This article has no abstract
Epistemonikos ID: 63a8f8e65d0095281a914a31ae68426e409549fb
First added on: Sep 10, 2024